Target intelligence / Profile preview

NGFI-A binding protein 1 pseudogene (NAB1P1)

Target
NAB1P1
Molecular classification
Other (Pseudogene)
01

Overview

NGFI-A binding protein 1 pseudogene (NAB1P1) is a non-coding DNA sequence classified as a pseudogene of the functional NAB1 gene, which itself encodes a transcriptional repressor that regulates zinc finger transcription factors such as EGR1 and EGR2[4][5][1]. Pseudogenes resemble functional genes but typically do not encode an active protein; their roles are largely unknown and they are not considered therapeutic targets or druggable receptors. NAB1P1's biological function, involvement in disease, or drug interactions have not been characterized in current literature, and there is no evidence it is used as a biomarker or target in any therapeutic context[6][2]. Additional context: - NAB1P1 is easily confused with its parent gene NAB1, but only NAB1 is a protein-coding gene with known biological and disease associations (e.g., Charcot-Marie-Tooth Disease Type 4)[4][5]. - NAB1P1 should not be classified as a receptor, enzyme, transporter, or similar target structure. - No interacting drugs or mechanisms of action are described for this pseudogene. - Pseudogenes can have regulatory roles or act as biomarkers in some cancers, but nothing specific is reported for NAB1P1[6][2].

Other names
NAB1P1NGFI-A binding protein 1 (EGR1 binding protein 1) pseudogeneNAB1 pseudogene 1

Beyond the preview

Go deeper on NGFI-A binding protein 1 pseudogene (NAB1P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NGFI-A binding protein 1 pseudogene (NAB1P1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call